ANIP News and Press, ANI Pharmaceuticals Inc. From 11/16/22

ANI Pharmaceuticals ( NASDAQ: ANIP ) said the U.S. Food and Drug Administration (FDA) approved its generic antibiotic trimethoprim tablets USP, 100 mg. Trimethoprim is an antibiotic used to treat bacterial infections. "As we continue to focus on bringing niche...

ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for Trimethoprim Tablets USP, 100 mg. ANI’s Trimethoprim Tablets are the generic ver...

ANI Pharmaceuticals, Inc. (ANIP) Q3 2022 Earnings Conference Call November 09, 2022, 08:00 AM ET Company Participants Judy DiClemente - IR Nikhil Lalwani - President and CEO Steve Carey - CFO Christopher Mutz - Head, Rare Disease Conference Call Partici...

ANI Pharmaceuticals press release ( NASDAQ: ANIP ): Q3 Non-GAAP EPS of $0.64 beats by $0.09 . Revenue of $83.8M (+61.0% Y/Y) beats by $5.44M . Adjusted non-GAAP EBITDA of $19.6M. Reiterates total Company net revenue guidance of $295 million to $315 million ...

Third Quarter 2022 Results: -- Net revenues of $83.8 million, net loss available to common shareholders of $(9.0) million and diluted GAAP loss per share of $(0.55) -- -- Adjusted non-GAAP EBITDA of $19.6 million and adjusted non-GAAP diluted earnings per share...

ANI Pharmaceuticals ( NASDAQ: ANIP ) is scheduled to announce Q3 earnings results on Wednesday, November 9th, before market open. The consensus EPS Estimate is $0.55 (-45.5% Y/Y) and the consensus Revenue Estimate is $78.36M (+50.5% Y/Y). Over the last 2 years, ANIP ...

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its third quarter 2022 financial results on Wednesday, November 9, 2022, prior to market open. Nikhil Lalwani, President and Chief Executive Of...

The following slide deck was published by ANI Pharmaceuticals, Inc. in conjunction with this event. For further details see: ANI Pharmaceuticals (ANIP) presents at H.C. Wainwright 24th Annual Global Investment Conference - Slideshow

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (“ANI” or the “Company”) today announced that Krista L. Davis will join the Company as Chief Human Resources Officer, effective September 12. Ms. Davis brings to the Company over 20 years of executive leadership ex...

ANI Pharmaceuticals, Inc. (“ANI” or “the Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the H.C. Wainwright 24 th Annual Global Investment Conference as fo...